Bulletin Marking a New Chapter of Excellence for the Venus Army Venus Army enters a new era of leadership, blending legacy with fresh ideas to drive growth, innovation, and meaningful impact. The team continues its mission to uplift communities, patients, and employees alike.
Bulletin Featured: Turning the Tide Against Superbugs MBL inhibitors could be India’s best shot at defeating deadly superbugs. In this expert article, Mr. Saransh Chaudhary, President – Global Critical Care at Venus Remedies and CEO of VMRC, shares why innovation and collaboration are key.
Bulletin Talent Loss and AMR Crisis: Featured in Hindustan Times As AMR rises, healthcare faces talent loss. Our Hindustan Times featured blog explores the link between workforce burnout and the increasing antimicrobial crisis.
The Grand Launch Featured Mrs. Ekta S. Chaudhary to Lead Venus Foundation We are immensely honored and delighted to announce the appointment of Mrs. Ekta S. Chaudhary as the new Chairperson of Venus Foundation. We are certain that this significant milestone will mark a new era of growth, inclusivity, and impactful change under her visionary leadership. Her presence adds not only strength
News Featured Venus Remedies partners with UK-based Infex Therapeutics to develop anti-bacterial MET-X in India Bringing a First-in-Class MBL Inhibitor to India: Venus Remedies Licenses MET-X Venus Remedies has taken a significant step in combating Antimicrobial Resistance (AMR) by securing exclusive licensing rights for MET-X, an innovative anti-bacterial drug from UK-based Infex Therapeutics. This landmark partnership will enable Venus Remedies to develop, gain regulatory approvals,
Bulletin Venus Remedies Achieves GMP Certification for Panchkula Infusion Line by Iraq Venus Remedies is yet again proud to announce a significant achievement in our journey toward excellence. Our Panchkula infusion line has received the prestigious GMP (Good Manufacturing Practices) certification from Iraq. This prestigious certification stands as proof of our resolute commitment to ensuring the highest standards of quality, safety, and
Bulletin Venus Remedies Receives Malaysian PIC/S GMP Approval for Pre-Filled Syringe Facility Venus Remedies is thrilled to announce a major achievement: our pre-filled syringe (PFS) manufacturing unit in Baddi has been awarded the prestigious PIC/S GMP certification by Malaysia’s National Pharmaceutical Regulatory Agency (NPRA). This is the first time our PFS facility has received accreditation under the Pharmaceutical Inspection Co-operation
Bulletin Breaking Barriers with Epigenetics in the Fight Against AMR We are delighted to share that Mr. Saransh Chaudhary, President of Global Critical Care at Venus Remedies Ltd and CEO of Venus Medicine Research Centre, has authored a compelling article published in Hindustan Times E-Paper. This insightful piece, titled "Opening Frontiers with Epigenetics in Battle Against AMR," sheds light on
Bulletin Venus Remedies Leads Conversations on Breakthrough Diagnostic Technologies In alignment with Venus Remedies’ commitment to driving innovation in healthcare, our President of Global Critical Care, Mr. Saransh Chaudhary, recently shared valuable insights with India Pharma Outlook. In this engaging interview, Mr. Chaudhary discussed the critical areas of sepsis and antimicrobial resistance (AMR), illuminating how innovations in diagnostics and
Events Venus Remedies Shaping Healthcare at CPhI Milan 2024 Milan, Italy – 8-10 October 2024 Venus Remedies was once again thrilled to be a part of CPhI this year, a significant global event for the pharmaceutical industry held in the stunning city of Milan. This event brought together key industry leaders from across the globe, highlighting the importance of innovation,
Accreditations & Approvals Venus Remedies Secures Key Approvals in Multiple Markets Pharma major Venus Remedies Limited has recently made significant progress in its global expansion by obtaining marketing approvals (MAs) for a wide range of drugs in different countries. We’re excited to share that Carboplatin and Carbol have been approved in Morocco, along with Bortezomib, Gemcitabine, Cefepime, and Oxaliplatin in
Bulletin Venus Showcases Key Brands at ROSA CON 2024 Venus recently participated in the prestigious ROSA CON 2024, a zonal conference focusing on orthopedic specialties held in Bikaner. This event gathered leading orthopedic professionals and industry experts, providing a vital platform for sharing knowledge and advancing practices in the field. During the conference, Venus proudly showcased its prominent brands:
Bulletin Venus Remedies Joins AMR Vivli to Combat Antimicrobial Resistance Venus Remedies is proud to announce its official membership in AMR Vivli, a global platform dedicated to sharing critical data on antimicrobial resistance (AMR). Supported by the Wellcome Trust, AMR Vivli provides a crucial platform for researchers, healthcare organizations, and industry leaders to collaborate in combating AMR, which has become
Publications R3SET's Innovative Wellness Products Spotlighted in Harper's Bazaar R3SET, our brand dedicated to enhancing daily wellness rituals through innovative and sustainable solutions, has been featured in the prestigious Harper's Bazaar magazine. The two-page article in the July 2024 edition, found on pages 78 and 79, highlights our unique approach and extensive product range that cater to a variety
Accreditations & Approvals Venus Remedies Secures Major Tenders from UNICEF and PAHO to Enhance Global Healthcare Venus Remedies Limited, a global leader in the pharmaceutical industry, has achieved significant milestones by securing two prestigious tenders from globally renowned organizations—UNICEF and the Pan American Health Organization (PAHO). These wins mark a pivotal moment in the company's journey towards enhancing healthcare access and outcomes worldwide. UNICEF Tender
